Agfa has received approval from the U.S. Air Force to operate its PACS technology. The company's Impax product line received a certificate of "networthiness" from the USAF by meeting guidelines defined by the Defense Information Systems Agency in
Agfa has received approval from the U.S. Air Force to operate its PACS technology. The company's Impax product line received a certificate of "networthiness" from the USAF by meeting guidelines defined by the Defense Information Systems Agency in accordance with Department of Defense regulations for IT security. Clearing those hurdles, specifically, were the Impax 4.5, the company's latest PACS; Impax Web1000, which provides secure remote access to enterprise-wide clinical images; and Agfa Mil-PACS RIS Gateway, which allows RIS and PACS technologies to communicate. The company has implemented more than $100 million in PACS and teleradiology systems at more than 75 DOD Medical Treatment Facilities worldwide, including 28 U.S. Navy warships and two U.S. Navy hospital ships.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.